Splenic abscess: a single institution study and review of the literature

Yonsei Med J. 2011 Mar;52(2):288-92. doi: 10.3349/ymj.2011.52.2.288.

Abstract

Purpose: The aim of this study was to review our experience with splenic abscesses, with respect to the relevant aspects of splenic abscesses and treatment outcomes.

Materials and methods: We reviewed the cases of 18 patients who had splenic abscesses and who were treated at our hospital from November 1993 to December 2008.

Results: The most common symptom at presentation was abdominal pain in 12 patients (66.7%). The median duration from symptom onset until establishment of a diagnosis was 22 days. Streptococcus viridans was the most common pathogen (27.8%), follow by Klebsiella pneumoniae (22.2%). The mortality rate during the inpatient period and the previous 90 days was 16.6%. Three of four patients with Klebsiella pneumoniae showed a single abscess pocket. Four patients (22.2%) underwent percutaneous drainage, eight (44.5%) received antibiotic treatment only and six (33.3%) underwent splenectomy.

Conclusion: There is no gold standard for treating splenic abscesses. Treatment should be customized for each patient.

Publication types

  • Review

MeSH terms

  • Abscess / diagnosis
  • Abscess / drug therapy
  • Abscess / microbiology
  • Abscess / surgery
  • Abscess / therapy*
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Drainage
  • Female
  • Humans
  • Klebsiella Infections / diagnosis
  • Klebsiella Infections / drug therapy
  • Klebsiella Infections / microbiology
  • Klebsiella Infections / surgery
  • Klebsiella pneumoniae
  • Male
  • Middle Aged
  • Splenectomy
  • Splenic Diseases / diagnosis
  • Splenic Diseases / drug therapy
  • Splenic Diseases / microbiology*
  • Splenic Diseases / surgery
  • Streptococcal Infections / diagnosis
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / microbiology
  • Streptococcal Infections / surgery
  • Treatment Outcome
  • Viridans Streptococci
  • Young Adult

Substances

  • Anti-Bacterial Agents